What question did this study set out to answer?

To review current and emerging therapeutic options for managing non-infectious scleritis.

April 1, 2026Open Access

Update on Therapy for Non-Infectious Scleritis

ARAllison RicheyUniversity of Minnesota VSVictoria SattarovaUniversity of Minnesota LKLaura J. KopplinUniversity of Wisconsin–Madison

Key Points

To review current and emerging therapeutic options for managing non-infectious scleritis.
Conducted a thorough literature review on scleritis management.
Reviewed various therapeutic agents, including topical and systemic options.
Evaluated the role of immunomodulatory therapies and biologics.
Identified key therapeutic agents effective for inflammatory control.
Highlighted the importance of long-term treatment strategies.
Discussed emerging therapies and their potential impact.

Abstract

Abstract: Non-infectious scleritis is a potentially vision threatening inflammatory disease which often requires long-term treatment. The general approach to management consists of a thorough systemic workup and subsequent selection of the most appropriate therapeutic agent(s) for inflammatory control. This article reviews current and emerging therapies for scleritis treatment, including topical agents, systemic non-steroidal anti-inflammatory drugs and corticosteroids, conventional immunomodulatory therapies, and biologics. Keywords: glucocorticoids, immunosuppressive agents, non-steroidal anti-inflammatory agents, therapeutics

Perguntar à IA

Bookmark

View Full Paper

Cite This Study

Richey et al. (Sun,) studied this question.

synapsesocial.com/papers/69ccb71716edfba7beb88ee5 https://doi.org/https://doi.org/10.2147/opth.s563490

Perguntar à IA

Bookmark

View Full Paper